ATE333877T1 - Amlopidinbezylat-tabletten mit verbesserter stabilität - Google Patents

Amlopidinbezylat-tabletten mit verbesserter stabilität

Info

Publication number: ATE333877T1
Authority: AT; Austria
Prior art keywords: weight; tablets; improved stability; amlopidine; bezylate
Prior art date: 2001-12-17

Application number

AT02788262T

Other languages

English (en)

Inventor

Pal Fekete

Ignacz Maria Kiralyne

Peter Toempe

Laszlone Gora

Palne Szentgroti

Huszar Magdolna Leventiszne

Palne Thuroczi

Magyar Olga Lonkaine

Original Assignee

Egyt Gyogyszervegyeszeti Gyar

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-12-17

Filing date

2002-12-17

Publication date

2006-08-15

2002-12-17 Application filed by Egyt Gyogyszervegyeszeti Gyar filed Critical Egyt Gyogyszervegyeszeti Gyar

2006-08-15 Application granted granted Critical

2006-08-15 Publication of ATE333877T1 publication Critical patent/ATE333877T1/de

Links

229920000168 Microcrystalline cellulose Polymers 0.000 abstract 2
239000004480 active ingredient Substances 0.000 abstract 2
HTIQEAQVCYTUBX-UHFFFAOYSA-N amlodipine Chemical compound CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1C1=CC=CC=C1Cl HTIQEAQVCYTUBX-UHFFFAOYSA-N 0.000 abstract 2
229960000528 amlodipine Drugs 0.000 abstract 2
239000003795 chemical substances by application Substances 0.000 abstract 2
239000000314 lubricant Substances 0.000 abstract 2
235000019813 microcrystalline cellulose Nutrition 0.000 abstract 2
239000008108 microcrystalline cellulose Substances 0.000 abstract 2
229940016286 microcrystalline cellulose Drugs 0.000 abstract 2
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 abstract 1
229940075614 colloidal silicon dioxide Drugs 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

AT02788262T 2001-12-17 2002-12-17 Amlopidinbezylat-tabletten mit verbesserter stabilität ATE333877T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
HU0105345A HU226642B1 (en)	2001-12-17	2001-12-17	Amlodipine bezylate tablets having extended stability and process for producing the same

Publications (1)

Publication Number	Publication Date
ATE333877T1 true ATE333877T1 (de)	2006-08-15

Family

ID=90000366

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT02788262T ATE333877T1 (de)	2001-12-17	2002-12-17	Amlopidinbezylat-tabletten mit verbesserter stabilität

Country Status (17)

Country	Link
EP (1)	EP1458384B1 (de)
AT (1)	ATE333877T1 (de)
AU (1)	AU2002353242A1 (de)
BG (1)	BG108807A (de)
CZ (1)	CZ2004791A3 (de)
DE (1)	DE60213464T2 (de)
EA (1)	EA006826B1 (de)
ES (1)	ES2269787T3 (de)
HR (1)	HRP20040582B1 (de)
HU (1)	HU226642B1 (de)
LT (1)	LT5241B (de)
LV (1)	LV13243B (de)
PL (1)	PL370420A1 (de)
RS (1)	RS54304A (de)
SK (1)	SK2862004A3 (de)
UA (1)	UA74968C2 (de)
WO (1)	WO2003051364A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2006059217A1 (en) *	2004-12-01	2006-06-08	Ranbaxy Laboratories Limited	Stable solid dosage forms of amlodipine besylate and processes for their preparation
RU2359672C1 (ru) *	2008-02-18	2009-06-27	Зао "Биоком"	Твердая лекарственная форма, предназначенная для лечения артериальной гипертензии и стенокардии, и способ ее получения
JO3239B1 (ar)	2008-09-22	2018-03-08	Novartis Ag	تركيبات جالينية من مركبات عضوية
JP4954961B2 (ja) *	2008-10-06	2012-06-20	大日本住友製薬株式会社	光安定性の向上した組成物
JP5689052B2 (ja) *	2011-12-26	2015-03-25	大日本住友製薬株式会社	光安定性の向上した組成物
CN107441495A (zh)	2012-02-17	2017-12-08	埃吉斯药物私人有限公司	稳定性提高的药物制剂
PL236001B1 (pl)	2012-12-21	2020-11-30	Adamed Spolka Z Ograniczona Odpowiedzialnoscia	Złożona kompozycja farmaceutyczna zawierająca kandesartan cyleksetylu oraz amlodypinę, sposób jej wytwarzania oraz jednostkowa postać dawkowania zawierająca tę kompozycję
US10350171B2 (en)	2017-07-06	2019-07-16	Dexcel Ltd.	Celecoxib and amlodipine formulation and method of making the same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8608335D0 (en) *	1986-04-04	1986-05-08	Pfizer Ltd	Pharmaceutically acceptable salts
DE19857716A1 (de) *	1998-12-15	2000-06-21	Bayer Ag	Neue feste Formulierung von Metrifonat
WO2003032954A1 (en) *	2001-10-17	2003-04-24	Dr. Reddy's Laboratories Ltd.	Stabilized pharmaceutical formulations containing amlodipine maleate

2001
- 2001-12-17 HU HU0105345A patent/HU226642B1/hu unknown
2002
- 2002-12-17 RS YU54304A patent/RS54304A/sr unknown
- 2002-12-17 AT AT02788262T patent/ATE333877T1/de not_active IP Right Cessation
- 2002-12-17 WO PCT/HU2002/000145 patent/WO2003051364A1/en not_active Ceased
- 2002-12-17 SK SK286-2004A patent/SK2862004A3/sk unknown
- 2002-12-17 ES ES02788262T patent/ES2269787T3/es not_active Expired - Lifetime
- 2002-12-17 DE DE60213464T patent/DE60213464T2/de not_active Expired - Fee Related
- 2002-12-17 HR HR20040582A patent/HRP20040582B1/xx not_active IP Right Cessation
- 2002-12-17 EP EP02788262A patent/EP1458384B1/de not_active Expired - Lifetime
- 2002-12-17 CZ CZ2004791A patent/CZ2004791A3/cs unknown
- 2002-12-17 PL PL02370420A patent/PL370420A1/xx not_active IP Right Cessation
- 2002-12-17 UA UA20040705877A patent/UA74968C2/uk unknown
- 2002-12-17 EA EA200400801A patent/EA006826B1/ru not_active IP Right Cessation
- 2002-12-17 AU AU2002353242A patent/AU2002353242A1/en not_active Abandoned
2004
- 2004-07-07 LT LT2004062A patent/LT5241B/lt not_active IP Right Cessation
- 2004-07-16 LV LVP-04-82A patent/LV13243B/en unknown
- 2004-07-16 BG BG108807A patent/BG108807A/xx unknown

Also Published As

Publication number	Publication date
LV13243B (en)	2005-05-20
EP1458384A1 (de)	2004-09-22
EA006826B1 (ru)	2006-04-28
HUP0105345A2 (hu)	2003-12-29
CZ2004791A3 (cs)	2004-10-13
RS54304A (sr)	2006-12-15
EA200400801A1 (ru)	2004-12-30
HRP20040582A2 (en)	2005-02-28
BG108807A (en)	2005-03-31
AU2002353242A1 (en)	2003-06-30
WO2003051364A1 (en)	2003-06-26
PL370420A1 (en)	2005-05-30
SK2862004A3 (en)	2004-11-03
HU226642B1 (en)	2009-05-28
DE60213464T2 (de)	2007-03-01
HRP20040582B1 (en)	2007-08-31
LT5241B (lt)	2005-07-25
EP1458384B1 (de)	2006-07-26
DE60213464D1 (de)	2006-09-07
HUP0105345D0 (en)	2002-02-28
LT2004062A (en)	2005-02-25
ES2269787T3 (es)	2007-04-01
HUP0105345A3 (en)	2007-08-28
UA74968C2 (en)	2006-02-15

Similar Documents

Publication	Publication Date	Title
TW200505406A (en)	2005-02-16	Pharmaceutical compositions comprising a basic respectively acidic drug compound, a surfactant and a physiologically tolerable water-soluble acid respectively base
MY144992A (en)	2011-12-15	Substituted 1,2,3,4-tetrahydroisoquinoline derivatives.
ATE286500T1 (de)	2005-01-15	1,2,3,4-tetrahydroisochinolin-derivate
CA2469369A1 (en)	2003-06-19	Compositions containing both sedative and non-sedative antihistamines
NO20011721D0 (no)	2001-04-05	N-aralkylaminotetraliner som ligander for neuropeptid Y Y5 reseptor
NO20042844L (no)	2004-08-23	4-(piperidyl- og pyrrolidyl-alkyl-ureido)-kinoliner som uprotensin II reseptor-antagonister
WO2001095856A3 (en)	2002-06-27	Urea derivative useful as an anti-cancer agent and process for preparing same
MY130441A (en)	2007-06-29	Solutions containing epinastin
UA90518C2 (ru)	2010-05-11	Фармацевтическая композиция в форме таблетки, которая имеет улучшеное всасывание при трансбукальном введение, которая содержит наркотический активный ингредиент и амин
MXPA04001686A (es)	2004-05-31	Combinaciones de productos activos fungicidas.
MXPA03008420A (es)	2004-03-16	Forma farmaceutica solida oralmente dispersa.
AU5499701A (en)	2001-10-30	A pyridine-1-oxide derivative, and process for its transformation into pharmaceutically effective compounds
ATE333877T1 (de)	2006-08-15	Amlopidinbezylat-tabletten mit verbesserter stabilität
MXPA03005221A (es)	2004-03-26	Composicion farmaceutica de dronedarona para administracion parenteral.
SE0102440D0 (sv)	2001-07-05	New compound
MXPA03000606A (es)	2004-04-02	Derivados de benzofurano y su uso como agentes antibacterianos.
HUP0600084A2 (en)	2006-06-28	Pharmaceutical compositions containing ascorbic acid derivatives, methods of production of the active ingredient
AU2002358819A1 (en)	2003-06-17	Aqueous base liquid pharmaceutical compositions in suspension form for the oral administration of ibuprofen
YU35303A (sh)	2006-03-03	Preparati n-(1-metiletilaminokarbonil)-4-(3-metilfenil-amino)-3-piridinsulfonamida i cikličnih oligosaharida
CA2338988A1 (en)	2000-02-17	Aqueous growth-regulating compositions
MXPA02012015A (es)	2003-06-09	Ligandos de receptores para integrinas.
SK281967B6 (sk)	2001-09-11	Kaptoprilové tablety a spôsob ich prípravy
AP2003002897A0 (en)	2003-12-31	Processes and intermediates for preparing benzyl epoxides
MY127289A (en)	2006-11-30	Caloporoside derivatives, process for the preparation thereof, and the use thereof
HUP0401943A3 (en)	2008-02-28	The use of 2alfa,3alfa, 17alfa-trihydroxy-5alfa-androstan-6-one as active ingredient for plant development regulation via increasing stress

Legal Events

Date

Code

Title

Description

2007-06-15

UEP

Publication of translation of european patent specification

Ref document number: 1458384

Country of ref document: EP

2008-09-15

REN

Ceased due to non-payment of the annual fee